Oral weight loss pill MK-4082 tested for drug interactions
NCT ID NCT07697625
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tests MK-4082, an experimental weight loss medicine taken as a pill, in healthy adults. Researchers want to see how the body processes MK-4082 when taken alone and when taken with diltiazem, a common heart medication. The goal is to understand any drug interactions and ensure safety before testing in people with higher body weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MK-4082
- What this could lead to
- If successful, this study could help determine safe dosing for MK-4082, a potential oral weight loss medicine.
- What could go wrong
- This is an early-phase study in healthy volunteers, not people with obesity. Results may not predict effectiveness or safety in the target population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Which medical adhesive stays put longest without itching? a head-to-head test in healthy women.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- New eye drop aims to tame ocular pain in early trial
- Could a formula closer to breast milk boost baby development?
- Could a daily probiotic help you feel fuller and eat less?